The
The agency told Pfizer it might not renew the pandemic-era authorization covering the youngest children, the company said in a statement. Pfizer has requested the authorization stay in place through the coming fall season and is “currently in discussions with the agency on potential paths forward,” the company said.
If Pfizer’s vaccine is no longer available for children as young as six months, kids with ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
